SCHEMBL107334

SCHEMBL107334

Cc1cc(CC(C)C)cc(C)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
POLB P06746 3/20 0.39
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
EPHX1 P07099 1/20 0.34
IKBKB O14920 1/20 0.33
XDH P47989 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGS1 P23219 2/20 0.31
PTGS2 P35354 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22604931 0.89 NOS3 (0.36) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL11142100 0.80 SHBG (0.39) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL9875129 0.79 ESR1 (0.47) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL11694229 0.78 GABRA1 (0.38) TSHRNOS3NOS1NOS2POLB
SCHEMBL28463478 0.77 ALDH1A1 (0.36) ALDH1A1CYP3A4TSHRTDP1NOS3
SCHEMBL28117219 0.76 GABRA1 (0.50) ALDH1A1NOS3NOS1NOS2POLB
SCHEMBL22604922 0.76 NOS3 (0.39) ALDH1A1CYP3A4TSHRNOS3NOS1
SCHEMBL8186747 0.76 CA1 (0.46) GABRA1GABRB2PTGS1PTGS2ESR1
SCHEMBL1312347 0.76 GABRA1 (0.46) ALDH1A1TSHRPOLBGABRA1GABRB2
SCHEMBL11511762 0.76 SKP2 (0.53) ALDH1A1CYP3A4TSHRTDP1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11913944-B2 Photoaffinity probes PROMEGA CORPORATION (US) 2024-02-27 US disclosed
US-20200340982-A1 PHOTOAFFINITY PROBES PROMEGA CORPORATION 2020-10-29 US disclosed
US-8481546-B2 CGRP receptor antagonist BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-09 US disclosed
US-20120059017-A1 CGRP Receptor Antagonist BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059017-A1 CGRP Receptor Antagonist CALCRL, PTGIR, CALCR ALDH1A1 1718/4885TP53 1972/4885CYP3A4 3127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.